Home » Topics » BioWorld Science

BioWorld Science
RSS

California Institute of Technology, Rockefeller University describe anti-HIV vaccine antibodies

Feb. 4, 2021

Novartis discovers AKR1C3-dependent GTPase KRAS inhibitors

Feb. 4, 2021

Cybrexa 3 patents peptide conjugates of microtubule-targeting agents

Feb. 4, 2021

New cannabinoid CB1 and CB2 receptor ligands identified at Canopy Growth Corp.

Feb. 4, 2021

Preliminary phase I data show safety and immunogenicity of VXA-CoV2-1 oral tablet vaccine

Feb. 4, 2021

Positive topline data from phase II study of Allocetra in severe and critical COVID-19

Feb. 4, 2021

Crinetics initiates phase I study of CRN-04777

Feb. 4, 2021

Multivalent nanobodies potently neutralize SARS-CoV-2 and prevent mutational escape

Feb. 4, 2021

A bivalent measles-based COVID-19 vaccine shows antiviral efficacy in vivo and Th1-biased responses

Feb. 4, 2021

FDA authorizes initiation of pivotal phase III study of NE-3107 in AD

Feb. 4, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...